Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 4
Submit an article Journal homepage
2,777
Views
51
CrossRef citations to date
0
Altmetric
Original Research

OX40 expression in hepatocellular carcinoma is associated with a distinct immune microenvironment, specific mutation signature, and poor prognosis

Kunlin XieDepartment of Liver Surgery & Liver Transplantation, West China Hospital, Sichuan University, Chengdu, Sichuan, ChinaView further author information
, MD,
Lin XuLaboratory of Liver Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, ChinaView further author information
, PhD,
Hao WuDepartment of Hepatobiliary Surgery, the Second Affiliated Hospital of Chongqing Medical university, Chongqing, ChinaView further author information
, MD,
Haotian LiaoDepartment of Liver Surgery & Liver Transplantation, West China Hospital, Sichuan University, Chengdu, Sichuan, ChinaView further author information
, MD,
Lin LuoDepartment of Liver Surgery & Liver Transplantation, West China Hospital, Sichuan University, Chengdu, Sichuan, ChinaView further author information
, MD,
Mingheng LiaoDepartment of Liver Surgery & Liver Transplantation, West China Hospital, Sichuan University, Chengdu, Sichuan, ChinaORCID Iconhttps://orcid.org/0000-0001-8627-2602View further author information
, MDORCID Icon,
Jianping GongDepartment of Hepatobiliary Surgery, the Second Affiliated Hospital of Chongqing Medical university, Chongqing, ChinaView further author information
, MD, PhD,
Yang DengDepartment of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaView further author information
, MD,
Kefei YuanLaboratory of Liver Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, ChinaCorrespondence[email protected] [email protected] [email protected]
View further author information
, PhD,
Hong WuDepartment of Liver Surgery & Liver Transplantation, West China Hospital, Sichuan University, Chengdu, Sichuan, China;Laboratory of Liver Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, ChinaCorrespondence[email protected] [email protected] [email protected]
View further author information
, MD, PhD &
Yong ZengDepartment of Liver Surgery & Liver Transplantation, West China Hospital, Sichuan University, Chengdu, Sichuan, China;Laboratory of Liver Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, ChinaCorrespondence[email protected] [email protected] [email protected]
View further author information
, MD, PhD show all
Article: e1404214 | Received 07 Aug 2017, Accepted 06 Nov 2017, Published online: 06 Mar 2018

Citations (51)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Hiroshi Yokouchi, Hiroshi Nishihara, Toshiyuki Harada, Toraji Amano, Takayuki Ohkuri, Shigeo Yamazaki, Hajime Kikuchi, Satoshi Oizumi, Hidetaka Uramoto, Fumihiro Tanaka, Masao Harada, Kenji Akie, Fumiko Sugaya, Yuka Fujita, Kei Takamura, Tetsuya Kojima, Mitsunori Higuchi, Osamu Honjo, Yoshinori Minami, Naomi Watanabe, Masaharu Nishimura, Hiroyuki Suzuki, Hirotoshi Dosaka-Akita & Hiroshi Isobe. (2021) Prognostic significance of OX40+ lymphocytes in tumor stroma of surgically resected small-cell lung cancer. OncoImmunology 10:1.
Read now
Jenny Sprooten, Jolien Ceusters, An Coosemans, Patrizia Agostinis, Steven De Vleeschouwer, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2019) Trial watch: dendritic cell vaccination for cancer immunotherapy. OncoImmunology 8:11.
Read now

Articles from other publishers (49)

Yaxiao Lu, Yang Li, Jingwei Yu, Shen Meng, Chengfeng Bi, Qingpei Guan, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Wenchen Gong, Bin Meng, Xiubao Ren, James Armitage, Huilai Zhang, Kai Fu & Xianhuo Wang. (2023) OX40 shapes an inflamed tumor immune microenvironment and predicts response to immunochemotherapy in diffuse large B-cell lymphoma. Clinical Immunology 251, pages 109637.
Crossref
Jonathan Charles, Andrea Vrionis, Arian Mansur, Trevor Mathias, Jamil Shaikh, Aaron Ciner, Yixing Jiang & Nariman Nezami. (2023) Potential Immunotherapy Targets for Liver-Directed Therapies, and the Current Scope of Immunotherapeutics for Liver-Related Malignancies. Cancers 15:9, pages 2624.
Crossref
Hao Chi, Songyun Zhao, Jinyan Yang, Xinrui Gao, Gaoge Peng, Jinhao Zhang, Xixi Xie, Guobin Song, Ke Xu, Zhijia Xia, Shi Chen & Jinqiu Zhao. (2023) T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing. Frontiers in Immunology 14.
Crossref
Di Wang, Huan Hu, Huan Ding, Han Zhao, Feifei Tian & Qingjia Chi. (2023) Elevated expression of TNFRSF4 impacts immune cell infiltration and gene mutation in hepatocellular carcinoma. Cancer Biomarkers 36:2, pages 147-159.
Crossref
Aliya Irshad Sani, Zila Rubab, Shumaila Usman, Syed Zaryab Ahmed & Sadia Arif. (2023) Costimulatory Molecules OX40 and OX40L Upregulation in Oral Squamous Cell Carcinoma: A Blood-Based Study. European Journal of Dentistry.
Crossref
Yinan Hu, Jingyi Liu, Jiahao Yu, Fangfang Yang, Miao Zhang, Yansheng Liu, Shuoyi Ma, Xia Zhou, Jingbo Wang & Ying Han. (2022) Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma. Cancer Cell International 22:1.
Crossref
Heng Ma, Peng-hui Feng, Shuang-ni Yu, Zhao-hui Lu, Qi Yu & Jie Chen. (2022) Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma. BMC Cancer 22:1.
Crossref
Yusai Xie, Wei Zhang, Jia Sun, Lingyan Sun, Fanjie Meng & Huiying Yu. (2022) A novel cuproptosis-related immune checkpoint gene signature identification and experimental validation in hepatocellular carcinoma. Scientific Reports 12:1.
Crossref
Isabelle Preddy, Khizar Nandoliya, Jason Miska & Atique U. Ahmed. (2022) Checkpoint: Inspecting the barriers in glioblastoma immunotherapies. Seminars in Cancer Biology 86, pages 473-481.
Crossref
Tianhao Cong, Yingen Luo, Yu Liu, Chao Yang, Hongcai Yang, Yujie Li, Jingui Li & Xiao Li. (2022) Cuproptosis-related immune checkpoint gene signature: Prediction of prognosis and immune response for hepatocellular carcinoma. Frontiers in Genetics 13.
Crossref
Haifeng Wan, Shan Lu, Lin Xu, Kefei Yuan, Yang Xiao, Kunlin Xie & Hong Wu. (2022) Immune-Related Biomarkers Improve Performance of Risk Prediction Models for Survival in Patients With Hepatocellular Carcinoma. Frontiers in Oncology 12.
Crossref
Li Tao, Xiaomeng Ren, Wenhui Zhai & Zheng Chen. (2022) Progress and Prospects of Non-Canonical NF-κB Signaling Pathway in the Regulation of Liver Diseases. Molecules 27:13, pages 4275.
Crossref
Zhen-Zhen Wang, Tao Meng, Ming-Ya Yang, Wei Wang, Yan Zhang, Yu Liu, An-Qi Han, Jin Wu, Hui-xiao Wang, Bo Qian & Li-Xin Zhu. (2022) ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma. Translational Oncology 21, pages 101441.
Crossref
Cecilia A. C. Lima, Mário R. Martins, Rogerio L. dos Santos, Luciana M. da Silva, Jeronimo P. A. Silva, Leuridan C. Torres & Nora M. Forones. (2022) High soluble OX40 levels correlate with metastatic gastric cancer. Journal of Surgical Oncology 126:1, pages 139-143.
Crossref
Qiwei Zhang, Weiwei Rui, Yongsheng Jiang, Fei Yuan, Yong Chen, Xiaoxia Guo, Yu Zhou, Zhiyuan Wu, Chaofu Wang & Xiaoyi Ding. (2022) Tumor-infiltrating OX40+ lymphocytes is an independent positive prognostic factor for patients with pancreatic ductal adenocarcinoma. Clinical and Translational Oncology 24:10, pages 2029-2038.
Crossref
Xiaojun Jin, Yongfei Song, Zhanglu An, Shanshan Wu, Dihui Cai, Yin Fu, Chuanjing Zhang, Lichao Chen, Wen Tang, Zequn Zheng, Hongsheng Lu & Jiangfang Lian. (2022) A Predictive Model for Prognosis and Therapeutic Response in Hepatocellular Carcinoma Based on a Panel of Three MED8-Related Immunomodulators. Frontiers in Oncology 12.
Crossref
Kevin Park, Mysore S. Veena & Daniel Sanghoon Shin. (2022) Key Players of the Immunosuppressive Tumor Microenvironment and Emerging Therapeutic Strategies. Frontiers in Cell and Developmental Biology 10.
Crossref
Qun Cai, Mingyan Zhu, Jinnan Duan, Hao Wang, Jingdan Chen, Yixin Xiao, Yangqin Wang, Jianfang Wang, Xuewen Yu & Hui Yang. (2022) Comprehensive Analysis of Immune-Related Prognosis of TK1 in Hepatocellular Carcinoma. Frontiers in Oncology 11.
Crossref
Guoying Zhou, Patrick P. C. Boor, Marco J. Bruno, Dave Sprengers & Jaap Kwekkeboom. (2021) Immune suppressive checkpoint interactions in the tumour microenvironment of primary liver cancers. British Journal of Cancer 126:1, pages 10-23.
Crossref
Peixin Chen, Hao Wang, Lishu Zhao, Haoyue Guo, Liping Zhang, Wei Zhang, Chenglong Sun, Sha Zhao, Wei Li, Jun Zhu, Jia Yu, Chunyan Wu & Yayi He. (2021) Immune Checkpoints OX40 and OX40L in Small-Cell Lung Cancer: Predict Prognosis and Modulate Immune Microenvironment. Frontiers in Oncology 11.
Crossref
He Ren, Wanjing Li, Xin Liu, Shuliang Li, Hao Guo, Wei Wang & Na Zhao. (2021) Identification and Validation of an 6-Metabolism-Related Gene Signature and Its Correlation With Immune Checkpoint in Hepatocellular Carcinoma. Frontiers in Oncology 11.
Crossref
Angelo Porciuncula, Micaela Morgado, Richa Gupta, Kostas Syrigos, Robert Meehan, Sima J. Zacharek, Joshua P. Frederick & Kurt A. Schalper. (2021) Spatial Mapping and Immunomodulatory Role of the OX40/OX40L Pathway in Human Non–Small Cell Lung Cancer. Clinical Cancer Research 27:22, pages 6174-6183.
Crossref
Binhua Pan, Modan Yang, Xuyong Wei, Wangyao Li, Kun Wang, Mengfan Yang, Di Lu, Rui Wang, Beini Cen & Xiao Xu. (2021) Interleukin-2 inducible T-cell kinase: a potential prognostic biomarker and tumor microenvironment remodeling indicator for hepatocellular carcinoma. Aging 13:14, pages 18620-18644.
Crossref
Aliya I Sani, Zil E Rubab, Shumaila Usman, Syed Zaryab Ahmed, Mervyn Hosein & Moazzam A Shahid. (2021) Serum Levels of OX40 in Early and Late-Stage Oral Squamous Cell Carcinoma. Cureus.
Crossref
Fengwei Gao, Kunlin Xie, Qiwen Xiang, Yan Qin, Panyu Chen, Haifeng Wan, Yang Deng, Jiwei Huang & Hong Wu. (2021) The density of tumor-infiltrating lymphocytes and prognosis in resectable hepatocellular carcinoma: a two-phase study. Aging 13:7, pages 9665-9678.
Crossref
Jingyi Zhou, Weiyu Wang & Qi Li. (2021) Potential therapeutic targets in the tumor microenvironment of hepatocellular carcinoma: reversing the protumor effect of tumor-associated macrophages. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Aliya I Sani, Zil-e-Rubab, Shumaila Usman, Syed Zaryab Ahmed & Mervyn Hosein. (2021) Role of OX40 and its ligand as costimulatory modulators in cancer immunotherapy. AIMS Molecular Science 8:3, pages 161-173.
Crossref
Mengzhou Guo, Feifei Yuan, Feng Qi, Jialei Sun, Qianwen Rao, Zhiying Zhao, Peixin Huang, Tingting Fang, Biwei Yang & Jinglin Xia. (2020) Expression and clinical significance of LAG-3, FGL1, PD-L1 and CD8+T cells in hepatocellular carcinoma using multiplex quantitative analysis. Journal of Translational Medicine 18:1.
Crossref
Bonnie S. Glisson, Rom S. Leidner, Robert L. Ferris, John Powderly, Naiyer A. Rizvi, Bhumsuk Keam, Reva Schneider, Sanjay Goel, James P. Ohr, Jennifer Burton, Yanan Zheng, Steven Eck, Matthew Gribbin, Katie Streicher, Danielle M. Townsley & Sandip Pravin Patel. (2020) Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors. Clinical Cancer Research 26:20, pages 5358-5367.
Crossref
Dengchuan Wang, Jun Liu, Shengshuo Liu & Wenli Li. (2020) Identification of Crucial Genes Associated With Immune Cell Infiltration in Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis. Frontiers in Genetics 11.
Crossref
Kefei Yuan, Kunlin Xie, Tian Lan, Lin Xu, Xiangzheng Chen, Xuefeng Li, Mingheng Liao, Jiaxin Li, Jiwei Huang, Yong Zeng & Hong Wu. (2019) TXNDC12 promotes EMT and metastasis of hepatocellular carcinoma cells via activation of β-catenin. Cell Death & Differentiation 27:4, pages 1355-1368.
Crossref
Su Jong Yu & Tim F. Greten. (2020) Deciphering and Reversing Immunosuppressive Cells in the Treatment of Hepatocellular Carcinoma. Journal of Liver Cancer 20:1, pages 1-16.
Crossref
Yin Zongyi & Li Xiaowu. (2020) Immunotherapy for hepatocellular carcinoma. Cancer Letters 470, pages 8-17.
Crossref
Xiaokang Shi, Bin Wang, Xiaoyan Chen, Yuyang Zheng, Youming Ding & Changhua Wang. (2020) Upregulation of ubiquitin-conjugating enzyme E2Z is associated with human hepatocellular carcinoma. Biochemical and Biophysical Research Communications 523:1, pages 25-32.
Crossref
Jumpei Kashima, Yusuke Okuma, Yukio Hosomi & Tsunekazu Hishima. (2020) High Serum OX40 and OX40 Ligand (OX40L) Levels Correlate with Reduced Survival in Patients with Advanced Lung Adenocarcinoma. Oncology 98:5, pages 303-310.
Crossref
Erminia Massarelli, Vincent K. Lam, Edwin R. Parra, Jaime Rodriguez-Canales, Carmen Behrens, Lixia Diao, Jing Wang, Jorge Blando, Lauren A. Byers, Niranjan Yanamandra, Sara Brett, Peter Morley, Padmanee Sharma, James Allison, Ignacio I. Wistuba & John V. Heymach. (2019) High OX-40 expression in the tumor immune infiltrate is a favorable prognostic factor of overall survival in non-small cell lung cancer. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Chen Lu, Dawei Rong, Betty Zhang, Wubin Zheng, Xuehao Wang, Ziyi Chen & Weiwei Tang. (2019) Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities. Molecular Cancer 18:1.
Crossref
Hua Jin, Chunpan Zhang, Chengyang Sun, Xinyan Zhao, Dan Tian, Wen Shi, Yue Tian, Kai Liu, Guangyong Sun, Hufeng Xu & Dong Zhang. (2019) OX40 expression in neutrophils promotes hepatic ischemia/reperfusion injury. JCI Insight 4:21.
Crossref
Wei Ding, Yulin Tan, Yan Qian, Wenbo Xue, Yibo Wang, Peng Jiang & Xuezhong Xu. (2019) Clinicopathologic and prognostic significance of tumor-associated macrophages in patients with hepatocellular carcinoma: A meta-analysis. PLOS ONE 14:10, pages e0223971.
Crossref
Haotian Liao, Wen Chen, Yunlu Dai, Joseph J. Richardson, Junling Guo, Kefei Yuan, Yong Zeng & Kunlin Xie. (2019) Expression of Programmed Cell Death-Ligands in Hepatocellular Carcinoma: Correlation With Immune Microenvironment and Survival Outcomes. Frontiers in Oncology 9.
Crossref
Wei Li, Lin Xu, Jun Han, Kefei Yuan & Hong Wu. (2019) Identification and Validation of Tumor Stromal Immunotype in Patients With Hepatocellular Carcinoma. Frontiers in Oncology 9.
Crossref
Peter R. Hoffmann, Fukun W. Hoffmann, Thomas A. Premeaux, Tsuyoshi Fujita, Elisa Soprana, Maddalena Panigada, Glen M. Chew, Guilhem Richard, Pooja Hindocha, Mark Menor, Vedbar S. Khadka, Youping Deng, Lenny Moise, Lishomwa C. Ndhlovu, Antonio Siccardi, Andrew D. Weinberg, Anne S. De Groot & Pietro Bertino. (2019) Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models. Frontiers in Oncology 9.
Crossref
Wei Li, Jun Han, Kefei Yuan & Hong Wu. (2019) Integrated tumor stromal features of hepatocellular carcinoma reveals two distinct subtypes with prognostic/predictive significance. Aging 11:13, pages 4478-4509.
Crossref
Zuzana Macek JilkovaCaroline AspordKeerthi KurmaAnouck GranonChristian SengelNathalie SturmPatrice N. MarcheThomas Decaens. (2019) Immunologic Features of Patients With Advanced Hepatocellular Carcinoma Before and During Sorafenib or Anti-programmed Death-1/Programmed Death-L1 Treatment. Clinical and Translational Gastroenterology 10:7, pages e00058.
Crossref
James J. Harding, Danny N. Khalil & Ghassan K. Abou-Alfa. (2019) Biomarkers: What Role Do They Play (If Any) for Diagnosis, Prognosis and Tumor Response Prediction for Hepatocellular Carcinoma?. Digestive Diseases and Sciences 64:4, pages 918-927.
Crossref
Haotian Liao, Mingheng Liao, Lin Xu, Xiaokai Yan, Bo Ren, Zexin Zhu, Kefei Yuan & Yong Zeng. (2019) Integrative analysis of h-prune as a potential therapeutic target for hepatocellular carcinoma. EBioMedicine 41, pages 310-319.
Crossref
Feifei Liu, Yanning Liu & Zhi Chen. (2018) Tim-3 expression and its role in hepatocellular carcinoma. Journal of Hematology & Oncology 11:1.
Crossref
Kathrin Rothfelder, Ilona Hagelstein, Malte Roerden, Gunnar Blumenstock, Martin Hofmann, Tina Nuebling, Gundram Jung, Helmut Rainer Salih & Daniela Dörfel. (2018) Expression of the Immune Checkpoint Modulator OX40 in Acute Lymphoblastic Leukemia Is Associated with BCR-ABL Positivity. Neoplasia 20:11, pages 1150-1160.
Crossref
Thomas T DeLeon, Yumei Zhou, Bolni M Nagalo, Raquel T Yokoda, Daniel H Ahn, Ramesh K Ramanathan, Marcela A Salomao, Bashar A Aqel, Amit Mahipal, Tanios S Bekaii-Saab & Mitesh J Borad. (2018) Novel immunotherapy strategies for hepatobiliary cancers. Immunotherapy 10:12, pages 1077-1091.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.